Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US Sen. Warren Joins Finance Panel With Focus On Medicare Payments, Taxes

Warren drops membership on Senate HELP committee for the move, but introduces new bill on emergency device and drug manufacturing

Executive Summary

Well-known Massachusetts Democrat gives up spot on health committee to join finance panel with focus on corporate taxes, trade deals and Medicare issues.

You may also be interested in...

Senators Urge FDA To Issue OTC Hearing Aid Regulations

Two US senators are pushing the agency to enact a final rule authorized in 2017 that would improve consumer access to affordable hearing aids.

Gottlieb Wants Timely Approval Of User Fee Bill, Balanced LDT Plan

FDA Commissioner-nominee Scott Gottlieb was approved by the Senate HELP committee April 27, sending his confirmation to the full Senate. Written responses from Gottlieb to senators' questions provided in advance of the vote don't hold any big surprises, but they provide a view into priorities of the incoming official and the lawmakers, including quick user-fee reauthorization, resolving the lab-developed test oversight debate, off-label and "right-to-try" issues and post-market surveillance.

UDIs Should Be Added To Insurance Claims, Panel Agrees

The X12 committee, a panel that helps sets standards for insurance documentation in the US, has agreed that Unique Device Identifiers should be added to Medicare and private-payer claims forms, a move that some groups say could make it easier to track long-term safety and performance of implants. But device companies oppose the move.


Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts